Subscribe to RSS Feed
Medicines-NovoNordisk-Sintez
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-NovoNordisk-Sintez
Currently Shopping by
-
Manufacturer:
NovoNordisk
Sintez
- The purpose of the medication
- Manufacturer
- Price
